4.5 Article

A Chlamydia effector combining deubiquitination and acetylation activities induces Golgi fragmentation

Journal

NATURE MICROBIOLOGY
Volume 3, Issue 12, Pages 1377-1384

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41564-018-0271-y

Keywords

-

Categories

Funding

  1. EU FP7 infrastructure grant BIOSTRUCT-X [283570]
  2. Medical Research Council [U105192732]
  3. European Research Council [724804]
  4. Lister Institute for Preventive Medicine
  5. EMBO Long-Term Fellowship
  6. National Institute of Allergy and Infectious Diseases [STI CRC U19 AI084044]
  7. North West Cancer Research
  8. National Institute of Health [R01AI100759]
  9. Medical Research Council
  10. European Research Council (ERC) [724804] Funding Source: European Research Council (ERC)
  11. MRC [MC_U105192732] Funding Source: UKRI

Ask authors/readers for more resources

Pathogenic bacteria are armed with potent effector proteins that subvert host signalling processes during infection(1). The activities of bacterial effectors and their associated roles within the host cell are often poorly understood, particularly for Chlamydia trachomatis(2), a World Health Organization designated neglected disease pathogen. We identify and explain remarkable dual Lys63-deubiquitinase (DUB) and Lys-acetyltransferase activities in the Chlamydia effector ChIaDUB1. Crystal structures capturing intermediate stages of each reaction reveal how the same catalytic centre of ChIaDUB1 can facilitate such distinct processes, and enable the generation of mutations that uncouple the two activities. Targeted Chlamydia mutant strains allow us to link the DUB activity of ChIaDUB1 and the related, dedicated DUB ChIaDUB2 to fragmentation of the host Golgi apparatus, a key process in Chlamydia infection for which effectors have remained elusive. Our work illustrates the incredible versatility of bacterial effector proteins, and provides important insights towards understanding Chlamydia pathogenesis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available